Tag: blood glucose measurement

  • Garmin Patent: New Method to Measure Hematocrit and Dehydration

    Garmin Patent: New Method to Measure Hematocrit and Dehydration

    Key Takeaways

    1. Garmin is developing a method to measure long-term blood glucose levels and other health parameters through new patent applications.
    2. The new technique, called pulse spectroscopy, evaluates blood flow non-invasively using electromagnetic radiation.
    3. The patent highlights the use of specific wavelengths (850 nm and 1,000 nm) to assess hematocrit levels in the blood.
    4. Monitoring hematocrit levels is crucial, especially for athletes, as it can indicate hydration status and overall blood composition.
    5. Real-time alerts for fluid intake based on hematocrit measurements could enhance performance monitoring for endurance athletes.


    Garmin’s wearables already track various health metrics, and the company is continually improving its sensor technology. Recently, a patent was published that shows Garmin is exploring a way to measure long-term blood glucose levels. Now, another patent (US-12343124-B2, which might only be found by a manual search here) has come to light, detailing the measurement of even more health parameters. It’s important to note that this is merely a patent application, meaning that the described measurement methods don’t necessarily have to comply with medical device standards, and not every innovation detailed in a patent ends up being sold commercially.

    Exploring Pulse Spectroscopy

    The patent focuses on a technique called pulse spectroscopy, which involves the non-invasive evaluation of blood flow using electromagnetic radiation. As expected, the patent includes a lot of technical drawings, diagrams, and absorption spectra. It also elaborates on how various wavelengths can be utilized to assess different health parameters. A notable innovation here is the application of electromagnetic radiation at wavelengths of 850 nm and 1,000 nm, which can reportedly assess hematocrit levels. This specific measure indicates the ratio of cellular components in the blood, particularly the amount of red blood cells in the total blood volume.

    Importance of Hematocrit Measurements

    This value is important in medical terms and can significantly increase in cases of dehydration caused by insufficient fluid intake. For a company like Garmin, which targets athletes, being able to monitor hematocrit levels could be quite advantageous. It would allow users to receive real-time alerts to boost their fluid intake based on solid data rather than just relying on heart rate or external conditions like temperature. Moreover, it’s common for endurance athletes to show lower hematocrit levels, so tracking this parameter could also give insights into long-term performance improvements.

    Source:
    Link

  • Garmin Unveils Non-Invasive Blood Sugar Measurement Technology

    Garmin Unveils Non-Invasive Blood Sugar Measurement Technology

    Key Takeaways

    1. Garmin has patented a method for measuring blood glucose levels, focusing on HbA1c, which reflects long-term glucose control.
    2. HbA1c is crucial for health insurance and monitoring diabetes progression, but it does not provide real-time glucose readings.
    3. Continuous Glucose Monitoring (CGM) systems can estimate HbA1c values using optical measurements of blood glucose levels.
    4. The patent involves pressure compensation and pulse spectrometry, capturing a wide spectrum of interactions between matter and radiation.
    5. The feasibility of this patent translating into a marketable product remains uncertain.


    Several firms are actively engaged in developing wrist-worn devices for monitoring blood glucose. In an earlier article, we explored the context and obstacles of this kind of measurement. Recently, Garmin has unveiled a new patent (patent number 20250134464) that outlines a method for measuring blood glucose levels, or at least a value associated with blood glucose.

    Understanding HbA1c

    The patent specifically mentions HbA1c, commonly known as long-term blood glucose, which gives insights into blood glucose levels over weeks. In numerous countries, determining HbA1c is essential for health insurance, especially for individuals with type 1 diabetes, and it helps in tracking the condition’s development. Simply put, the HbA1c value reflects red blood cells that have undergone a specific, irreversible chemical reaction with glucose. It’s critical to note that while HbA1c cannot provide real-time blood glucose readings, it can be estimated using Continuous Glucose Monitoring (CGM) systems that optically measure blood glucose levels.

    Technical Aspects of the Patent

    In essence, the patent discusses pressure compensation alongside a method known as pulse spectrometry. The term “spectrometry” means capturing a whole spectrum—the interaction between matter and radiation across a certain electromagnetic range—not just single wavelengths, as seen in heart rate or blood oxygen saturation measurements. The process of measuring the HbA1c value might be simpler due to its unique progression. However, to directly measure blood glucose levels, relatively advanced Near Infrared (NIR) sensors might be required. As always, it is uncertain if this patent will lead to an actual product in the market.

    Source:
    Link